Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Long Term Incentive Plan Second Vesting

25 Jun 2019 09:17

RNS Number : 3256D
Biome Technologies PLC
25 June 2019
 

 

 

 

25 June 2019

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Long Term Incentive Plan (the "2017 LTIP") Second Vesting

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, announces that pursuant to the Company's 2017 LTIP, the second vesting of options has occurred.

 

The 2017 LTIP was announced on 21 December 2017 setting share performance hurdles to achieve the vesting of options thereby further aligning the interests of the Company's management with Biome's shareholders. Details of the second vesting of the 2017 LTIP, which occurred on 10 June 2019, can be found below, with the following options now having vested and are available to be exercised under the terms of the rules of the scheme.

 

 

Name of Individual

 

Options vested and available for exercise

 

Exercise price per share

Paul Mines (Director)

17,304

215 pence

Declan Brown (Director)

8,075

215 pence

Other Employees

10,382

215 pence

Total

35,761

 

 

The Company also announced on 21 December 2017 that an award had been made to John Standen, subject to the same performance criteria as the 2017 LTIP. Under this scheme no additional amount is payable to Mr Standen in respect of the second vesting on 10 June 2019.

 

 

 

-Ends-

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited. Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers. Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

In 2018, the Board adopted the following three high level KPIs for the next three years to continue its ambitious momentum:

· Compound revenue growth of 25% per annum across the Group and 40% compound revenue growth in the Bioplastics division

· Diversify the Group's turnover by product and market to ensure that no one product or end customer contributes more than 15% of revenues by 2020

· Increase investment in the Group's next generation of products by spending significantly more per annum on average than the £0.3m per annum average spend over the previous strategic objective cycle

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMMGZVRKDGLZG
Date   Source Headline
27th Mar 20192:05 pmRNSSecond Price Monitoring Extn
27th Mar 20192:00 pmRNSPrice Monitoring Extension
13th Mar 20191:54 pmRNSHoldings in Company
24th Jan 20197:00 amRNSPre-close Trading Statement
31st Dec 20187:00 amRNSTotal Voting Rights
10th Dec 20182:35 pmRNS2017 Long Term Incentive Plan - First Vesting
6th Dec 20187:00 amRNSGrant funding from Innovate UK
23rd Nov 201812:38 pmRNSBiome to present at Mello London
1st Nov 20187:00 amRNSTrading update
3rd Sep 20187:00 amRNSInterim Results
23rd Jul 20187:00 amRNSTrading Update
31st May 20185:00 pmRNSTotal Voting Rights
2nd May 20184:13 pmRNSIssue of shares to directors & PDMR shareholdings
2nd May 20183:27 pmRNSProposed issue of shares to directors and dealings
24th Apr 201810:40 amRNSResult of Annual General Meeting
24th Apr 20187:00 amRNSTrading update
28th Mar 20181:52 pmRNSNotice of AGM and Annual Report and Accounts
27th Mar 20187:00 amRNSPreliminary Results
19th Feb 20182:05 pmRNSSecond Price Monitoring Extn
19th Feb 20182:00 pmRNSPrice Monitoring Extension
25th Jan 20187:00 amRNSPre-close Trading Statement
21st Dec 20177:00 amRNSNew LTIP and option grant
1st Nov 20177:00 amRNSTrading Update
4th Sep 20177:00 amRNSHalf-year Report
26th Jul 20179:30 amRNSDirector/PDMR Shareholding
25th Jul 20174:50 pmRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSTrading Update
24th Apr 201710:45 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Update
31st Mar 20172:50 pmRNSNotice of AGM and Annual Report and Accounts
29th Mar 20177:00 amRNSPreliminary Results
20th Jan 20177:00 amRNSPre-close Trading Statement
18th Jan 20177:00 amRNSSettlement Agreement
2nd Nov 20167:00 amRNSTrading Update
31st Aug 20167:00 amRNSHalf-year Report
27th Jun 20167:00 amRNSTrading Update
25th Apr 201612:34 pmRNSResult of Annual General Meeting
25th Apr 20167:00 amRNSTrading Update
1st Apr 201610:42 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 20167:00 amRNSFinal Results
26th Jan 20167:00 amRNSPre-close Trading Statement
3rd Nov 20157:00 amRNSTrading Statement
2nd Sep 20157:00 amRNSInterim Results
23rd Jul 20157:00 amRNSTrading Update
19th Jun 20159:00 amRNSNew Contract
27th Apr 20154:46 pmRNSResult of AGM
27th Apr 20157:00 amRNSTrading Update
27th Mar 20153:43 pmRNSNotice of Annual General Meeting
25th Mar 20157:00 amRNSPreliminary Results
19th Feb 20153:26 pmRNSFunding Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.